Zhen Ping Zhu
Director/Board Member at Refuge Biotechnologies, Inc.
Zhen Ping Zhu active positions
Companies | Position | Start | End |
---|---|---|---|
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA. | Director/Board Member | 02/05/2018 | - |
Numab Therapeutics AG
Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland. | Director/Board Member | 01/03/2018 | - |
Career history of Zhen Ping Zhu
Former positions of Zhen Ping Zhu
Companies | Position | Start | End |
---|---|---|---|
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Director/Board Member | 19/06/2019 | 13/01/2022 |
Chief Tech/Sci/R&D Officer | 19/06/2019 | 13/01/2022 | |
3SBIO INC. | Chief Tech/Sci/R&D Officer | 09/01/2017 | 01/09/2019 |
KADMON HOLDINGS, INC. | Corporate Officer/Principal | - | 06/01/2017 |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2010 | 01/01/2016 |
ImClone Systems LLC
ImClone Systems LLC BiotechnologyHealth Technology Part of Eli Lilly & Co., ImClone Systems LLC is a company that develops and manufactures biologics for the treatment of cancer. The company is based in Bridgewater, NJ. | Corporate Officer/Principal | - | - |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Chief Tech/Sci/R&D Officer | 15/11/2010 | - |
Corporate Officer/Principal | - | - |
Training of Zhen Ping Zhu
Dalhousie University | Doctorate Degree |
Jiangxi Medical College | Doctorate Degree |
Chinese Academy of Medical Sciences | Graduate Degree |
Peking Union Medical College | Graduate Degree |
Statistics
International
United States | 6 |
China | 5 |
Cayman Islands | 2 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 3 |
Sectoral
Health Technology | 7 |
Consumer Services | 5 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
3SBIO INC. | Health Technology |
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD | Health Technology |
Private companies | 6 |
---|---|
Kadmon Holdings, Inc.
Kadmon Holdings, Inc. BiotechnologyHealth Technology Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY. | Health Technology |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kadmon Pharmaceuticals LLC manufactures and distributes pharmaceutical products. The company is headquartered in Warrendale, PA. | Health Technology |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
Numab Therapeutics AG
Numab Therapeutics AG Miscellaneous Commercial ServicesCommercial Services Numab Therapeutics AG is a biopharmaceutical company, which engages in the development of cancer immunotherapy. Its focuses on creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. The company was founded by Oliver Middendorp, David Urech, and Peter Lichtlen in 2011 and is headquartered in Wadenswil, Switzerland. | Commercial Services |
ImClone Systems LLC
ImClone Systems LLC BiotechnologyHealth Technology Part of Eli Lilly & Co., ImClone Systems LLC is a company that develops and manufactures biologics for the treatment of cancer. The company is based in Bridgewater, NJ. | Health Technology |
Refuge Biotechnologies, Inc.
Refuge Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Refuge Biotechnologies, Inc. develops therapeutic cells. It is leveraging gene engineering technologies known as CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) to develop therapeutic cells that are programmed to make decisions inside the patient’s body. The firms programs include RB-1916, RB-H21 and RB-M1. The company was founded by Stanley Qi, David R. Parkinson and Bing C. Wang and is headquartered in Menlo Park, CA. | Commercial Services |
- Stock Market
- Insiders
- Zhen Ping Zhu
- Experience